|
GLOD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.20290000002765E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20120000005153E-06 |
| Normal-vs-Stage2 |
6.159400E-03 |
| Normal-vs-Stage3 |
6.794200E-04 |
| Normal-vs-Stage4 |
1.030870E-04 |
| Stage1-vs-Stage2 |
3.522800E-01 |
| Stage1-vs-Stage3 |
2.958000E-01 |
| Stage1-vs-Stage4 |
7.733400E-01 |
| Stage2-vs-Stage3 |
8.861600E-01 |
| Stage2-vs-Stage4 |
3.467000E-01 |
| Stage3-vs-Stage4 |
3.310600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51055999999539E-05 |
| Normal-vs-AfricanAmerican |
8.667800E-02 |
| Normal-vs-Asian |
1.443040E-03 |
| Caucasian-vs-AfricanAmerican |
2.109200E-01 |
| Caucasian-vs-Asian |
8.971600E-01 |
| AfricanAmerican-vs-Asian |
3.453600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.0604000002028E-07 |
| Normal-vs-Female |
5.80000000000025E-05 |
| Male-vs-Female |
9.847600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.96109999994754E-06 |
| Normal-vs-Age(41-60Yrs) |
5.562200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.150550E-04 |
| Normal-vs-Age(81-100Yrs) |
1.396440E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.161360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.750800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.688400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.210000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.126600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.924600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.171200E-01 |
| Classical-VS-Follicular |
2.960400E-01 |
| Classical-VS-Other |
4.165000E-01 |
| Classical-VS-Normal |
3.67610000000518E-05 |
| Tall-VS-Follicular |
1.652200E-01 |
| Tall-VS-Other |
2.930000E-01 |
| Tall-VS-Normal |
3.595800E-02 |
| Follicular-VS-Other |
7.754800E-01 |
| Follicular-VS-Normal |
1.152130E-04 |
| Other-VS-Normal |
2.716300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.63809999999387E-05 |
| Normal-vs-N1 |
1.86130000001672E-06 |
| N0-vs-N1 |
6.997800E-02 |
|
|
